Matthew Davidson

Harnessing synthetic lethality to predict the response to cancer treatment

Joo Sang Lee, Avinash Das, Livnat Jerby‐Arnon et al. · Nature Communications · 2018 · 143 citations · Full text

Medicine, Bioinformatics, Oncology +16

Erythropoietin drives breast cancer progression by activation of its receptor EPOR

Ka Kui Chan, Kyle B. Matchett, Jonathan A. Coulter et al. · Oncotarget · 2017 · 38 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum

Lawrence F. Eichenfield, Wendy McFalda, Bradford Brabec et al. · JAMA Dermatology · 2020 · 32 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum

Lawrence F. Eichenfield, Elaine C. Siegfried, Pearl Kwong et al. · American Journal of Clinical Dermatology · 2021 · 19 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +8